Blog Archives

Potenzielles Risiko von Herzrhythmusstörungen mit Fenspirid-haltigen Arzneimitteln

17. Februar 2019 – Fenspirid-haltige Arzneimittel scheinen ein potenzielles Risiko von Herzrhythmusstörungen zu beinhalten. Dies geht aus einem Beschluss des Ausschuss für Risikobewertung im Bereich der Pharmakovigilanz (PRAC) der European Medicines Agency (EMA) hervor, welcher eine Europa-weite Aussetzung von Fenspirid-haltigen Arzneimitteln empfohlen hat.

Read more ›

Tags: , , , , , , , , , , , ,

thasso: zustände

thasso: neueste tweets

thasso: kürzliche kommentare

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • How genetic variation gives rise to differences in mathematical ability October 22, 2020
    DNA variation in a gene called ROBO1 is associated with early anatomical differences in a brain region that plays a key role in quantity representation, potentially explaining how genetic variability might shape mathematical performance in children, according to a study published October 22nd in the open-access journal PLOS Biology by Michael Skeide of the Max […]
  • High-quality cat genome helps identify novel cause of dwarfism October 22, 2020
    A new and improved cat genome developed by the feline research teams at the University of Missouri and Texas A&M University has already proven to be a valuable tool for feline biomedical research by helping to confirm existing gene variants and new candidate genes underlying diseases in cats. The new findings are published October 22nd […]
  • Multiple sclerosis as the flip side of immune fitness October 22, 2020
    About half of the people with multiple sclerosis have the HLA-DR15 gene variant. A study led by the University of Zurich has now shown how this genetic predisposition contributes to the development of the autoimmune disease multiple sclerosis in combination with environmental factors. The decisive factor is the shaping of a repertoire of immune cells […]
  • Scientists use gene therapy and a novel light-sensing protein to restore vision in mice October 22, 2020
    A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy. The National Eye Institute, part of the National Institutes of Health, provided a Small Business Innovation Research grant to Nanoscope, LLC for development of MCO1. The company is planning a U.S. clinical […]
  • Diagnostic, therapeutic advance for rare neurodegenerative disorder October 21, 2020
    Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3)—a disease that has no cure. They also have clarified the role of a gene target associated with the disease.
Top